| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Richard D. Francis CEO | OTC PINK Exchange | IL0006290147 ISIN |
| IL Country | 37,000 Employees | 11 Nov 2010 Last Dividend | 11 Dec 2002 Last Split | - IPO Date |
Teva Pharmaceutical Industries Limited is a global leader in the development, manufacturing, marketing, and distribution of both generic and specialty medicines, as well as biopharmaceutical products. With operations spanning North America, Europe, Israel, and internationally, Teva focuses on providing a wide range of health solutions. The company is known for its extensive portfolio which includes various dosage forms like tablets, capsules, injectables, and more, tailored to treat a vast spectrum of conditions. Teva dedicates significant efforts to areas such as the central nervous system (CNS), respiratory, and oncology, aiming to advance healthcare and improve the quality of life for patients around the world. Established in 1901 and headquartered in Tel Aviv, Israel, Teva also engages in the production of active pharmaceutical ingredients and offers contract manufacturing services, supporting other entities in the pharmaceutical industry through an out-licensing platform.